News related to Epivir-HBV (Lamivudine) and/or conditions it is approved for
lamivudine and zidovudine, Combivir
Source: MedicineNet abacavir Specialty [2005.09.26]
Title: lamivudine and zidovudine, Combivir
Category: Medications
Created: 11/8/2000 8:14:00 PM
Last Editorial Review: 9/26/2005
New Data Suggest Long-Term Treatment With BARACLUDE® (entecavir) May Reduce Liver Damage Caused By Chronic Hepatitis B
Source: Liver Disease / Hepatitis News From Medical News Today [2008.11.06]
Bristol-Myers Squibb Company (NYSE:BMY) announced data from two separate cohort evaluations, in which long-term treatment with BARACLUDE® (entecavir) was associated with improved liver histology, including improvement in fibrosis, in chronic hepatitis B patients. The histology data were presented at the 59th Annual Meeting of the American Association for the Study of Liver Diseases.
|
